Infectious Burden and Carotid Plaque Thickness: The Northern Manhattan Study

Stroke

Volumn 41, Issue 3, 2010, Pages

  Elkind, Mitchell S V ^a   Luna, Jorge M ^b   Moon, Yeseon Park ^a   Boden Albala, Bernadette ^a   Liu, Khin M ^a   Spitalnik, Steven ^a   Rundek, Tanja ^c   Sacco, Ralph L ^c,d   Paik, Myunghee C ^b  

^a Columbia University ^*  (United States)

^b University of Miami ^*  (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Carotid artery; Carotid stenosis; Epidemiology; Infectious disease; Inflammation; Neursonology; Risk factors

Indexed keywords

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; FEMALE; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; THICKNESS;

AGED; ATHEROSCLEROSIS; BACTERIAL INFECTIONS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; VIRUS DISEASES;

EID: 77649152193     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.571299     Document Type: Article

References (44)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340:115-126.
2. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol. 2003;14:421-430.
3. Eriksson EE, Xie X, Werr J, Thoren P, Lindbom L. Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med. 2001;194:205-218.
4. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
5. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 1991;11: 1223-1230.
6. Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002;288: 2724-2731.
7. Wimmer MLJ, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996;27: 2207-2210.
8. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke. 1998;29:404-410.
9. Elkind MS, Tondella ML, Feikin DR, Fields BS, Homma S, Di Tullio MR. Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke. 2006;37:790-795.
10. Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998;98:2796-2799.
11. Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, Beck G, Neundoerfer B, Kolominsky-Rabas PL. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study. Stroke. 2001;32:2253-2258.
12. Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, Morrison RP, Xu Q, Wick G. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:1060-1065.
13. Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA. The human cytomega-lovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell. 1999;99:511-520.
14. Gredmark S, Tilburgs T, Söderberg-Naucler C. Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J Virol. 2004;78: 10378-10389.
15. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol. 2000;85:140-146.
16. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J; AtheroGene Investigators. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15-21. (Pubitemid 34049136)
17. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, Hafner G, Prellwitz W, Schlumberger W, Meyer J. Impact of infectious burden on progression of carotid atherosclerosis. Stroke. 2002; 33:2581-2586. (Pubitemid 35266427)
18. Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q, Dzavik V, McQueen M, Yusuf S; Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2003;107:251-257. (Pubitemid 36135220)
19. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RLS. Carotid plaque thickness predicts ischemic stroke, myocardial infarction and vascular death: the Northern Manhattan Study. Neurology. 2008;70: 1200-1207.
20. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a tri-ethnic cohort: the Northern Manhattan Study. Stroke. 2004;35:2263-2269. (Pubitemid 39311247)
21. Elkind MSV, Sciacca R, Boden-Albala B, Rundek T, Paik MC, Sacco RL. Relative elevation in leukocyte count predicts first cerebral infarction. Neurology. 2005;64:2121-2125.
22. Prabhakaran S, Rundek T, Ramas R, Elkind MS, Paik MC, Boden-Albala B, Sacco RL. Carotid plaque surface irregularity predicts ischemic stroke: the Northern Manhattan Study. Stroke. 2006;37:2696-2701.
23. Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Behavioral Risk Factor Surveillance System. 2008. Available at: www.cdc.gov/BRFSS/; www.cdc. gov/BRFSS/. Accessed May 26, 2009.
24. Gentry EM, Kalsbeek WD, Hogelin GC, Jones JT, Gaines KL, Forman MR, Marks JS, Trowbridge FL. The Behavioral Risk Factor Surveys: II. Design, methods, and estimate from combined state data. Am J Prev Med. 1985;1:9-14.
25. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: the Northern Manhattan Stroke Study. Stroke. 2000;31:1521-1525.
26. Sacco RL, Roberts JK, Boden-Albala B, Gu Q, Lin I-F, Kargman DE, Berglund L, Hauser WA, Shea S, Paik MC. Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. Stroke. 1997;28:929-935.
27. Elkind MSV, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM, Spitalnik SL, Rundek T, Sacco RL, Paik MC. Infectious burden and risk of stroke: the Northern Manhattan Study. Arch Neurol. 2009. Epub ahead of print. PMID: 19901154.
28. LaBiche R, Koziol D, Quinn TC, Gaydos C, Azhar S, Ketron G, Sood S, DeGraba TJ. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke. 2001;32: 855-860. (Pubitemid 32285148)
29. Agmon Y, Khandheria BK, Meissner I, Petterson TM, O'Fallon WM, Christianson TJ, Wiebers DO, Smith TF, Steckelberg JM, Tajik AJ. Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: a population-based transesophageal echocardio-graphic study. J Am Coll Cardiol. 2003;41:1482-1487.
30. Haider AW, Wilson PW, Larson MG, Evans JC, Michelson EL, Wolf PA, O'Donnell CJ, Levy D. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol. 2002;40: 1408-1413.
31. Schmal M, Marini C, Carolei A, Di Napoli M, Kessels F, Lodder J. Different vascular risk factor profiles among cortical infarcts, small deep infarcts, and primary intracerebral haemorrhage point to different types of underlying vasculopathy. A study from the L'Aquila Stroke Registry. Cerebrovasc Dis. 1998;8:14-19.
32. Kis Z, Sas K, Gyulai Z, Treso B, Petrovay F, Kapusinszky B, Csire M, Endresz V, Burian K, Mandi Y, Vecesi L, Gonczol E. Chronic infections and genetic factors in the development of ischemic stroke. New Microbiol. 2007;30:213-220.
33. Tarnacka B, Gromadzka G, Czlonkowska A. Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke. 2002;33:936-940.
34. Coles KA, Knuiman MW, Plant AJ, Riley TV, Smith DW, Divitini ML. A prospective study of infection and cardiovascular diseases: the Bus-selton Health Study. Eur J Cardiovasc Prev Rehabil. 2003;10:278-282.
35. Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E, Kes S, Tokgozoglu L. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol. 2000;38:4408-4411.
36. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis. 1998;177:725-729.
37. Hajjar DP, Fabricant CG, Minick CR, Fabricant J. Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol. 1986;122:62-70.
38. Grundy JE, Downes KL. Up-regulation of LFA-3 and ICAM-I on the surface of fibroblasts infected with cytomegalovirus. Immunology. 1993; 78:405-412.
39. Zhou YF, Yu ZX, Wanishsawad C, Shou M, Epstein SE. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF b-receptor. Biochem Biophys Res Commun. 1999;256:608-613.
40. van Dam-Mieras MCD, Muller AD, van Hinsbergh VWM, Muller WJ, Bomans PH, Bruggeman CA. The procoagulant response of cytomega-lovirus infected endothelial cells. Thromb Haemost. 1992;8:364-370.
41. Zhao ZS, Granucci F, Yeh L, Schaffer P, Cantor H. Molecular mimicry by herpes simplex virus type-1: autoimmune disease after viral infection. Science. 1998;279:1344-1348.
42. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke. 1999;30: 299-305.
43. O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA. 2003;290:1459-1466.
44. Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muhlestein B, Giugliano RP, Cairns R, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med. 2005;352:1646-1654.